| Lactose (India) Ltd | 122 Cr. | 97.0 | 193/84.3 | 27.0 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.21 Cr. | 1.68 | 4.29/1.68 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 3,473 Cr. | 319 | 479/192 | 71.9 | 24.3 | 0.21 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.9 Cr. | 44.3 | 82.8/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 73.2 Cr. | 50.0 | 50.0/17.0 | 174 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 64.9 Cr. | 86.2 | 115/69.7 | 17.5 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 54,194 Cr. | 1,920 | 2,286/1,275 | 20.0 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 300 Cr. | 12.3 | 17.2/10.8 | 18.0 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.09 Cr. | 12.0 | 14.8/9.25 | 88.6 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 856 Cr. | 1,595 | 1,999/635 | 29.6 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 91.6 Cr. | 18.3 | 29.8/17.0 | 25.0 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 963 Cr. | 327 | 449/219 | 8.60 | 133 | 0.76 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 2.89 Cr. | 13.8 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 7.37 Cr. | 2.96 | 8.28/2.11 | 4.19 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 390 Cr. | 402 | 536/211 | 59.0 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,918 Cr. | 1,130 | 1,565/944 | 44.5 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 47.0 Cr. | 0.23 | 1.12/0.20 | 3.09 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 37.8 Cr. | 14.4 | 26.3/11.2 | 18.4 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 7.85 Cr. | 7.77 | 14.9/7.50 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 166 Cr. | 465 | 851/415 | 9.41 | 596 | 0.32 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 77.0 Cr. | 77.0 | 92.5/26.1 | 145 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 11,602 Cr. | 1,109 | 2,452/1,100 | 36.1 | 174 | 0.96 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 9.58 Cr. | 76.0 | 88.7/36.1 | 19.6 | 39.2 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.5 Cr. | 5.01 | 7.66/2.99 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 17.2 Cr. | 114 | 153/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 62.6 Cr. | 114 | 144/10.0 | 30.4 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 31.8 Cr. | 42.1 | 73.0/33.0 | 51.2 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 5.78 Cr. | 19.2 | 24.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 7,059 Cr. | 407 | 1,028/392 | 20.0 | 72.4 | 0.29 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 82.9 Cr. | 19.2 | 28.8/16.6 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.1 Cr. | 21.9 | 37.5/17.4 | 48.4 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 85,195 Cr. | 2,064 | 2,727/2,047 | 51.1 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 214 Cr. | 372 | 524/241 | 22.0 | 123 | 1.21 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 57.4 Cr. | 40.0 | 47.9/26.7 | 89.7 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 68,012 Cr. | 1,171 | 1,279/994 | 19.9 | 603 | 0.34 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 140 Cr. | 225 | 303/159 | 134 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 719 Cr. | 71.7 | 115/68.0 | 18.6 | 32.6 | 2.09 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 32.6 Cr. | 25.0 | 42.8/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 15,860 Cr. | 1,937 | 1,968/930 | 55.3 | 173 | 0.08 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.36 Cr. | 0.66 | 1.06/0.51 | 62.3 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 212 Cr. | 27.7 | 53.8/23.1 | 13.6 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 7.30 Cr. | 12.5 | 19.1/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 123 Cr. | 5.23 | 6.57/2.82 | | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 58,066 Cr. | 27,325 | 37,000/25,950 | 38.5 | 1,888 | 1.74 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,993 Cr. | 772 | 972/557 | 29.2 | 226 | 0.65 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 182 Cr. | 64.0 | 100/31.3 | 50.7 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,308 Cr. | 1,275 | 1,740/752 | | 103 | 0.08 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 21,382 Cr. | 1,316 | 1,870/1,110 | 390 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 750 Cr. | 215 | 330/154 | 17.4 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 73.1 Cr. | 8.82 | 29.4/6.65 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,052 Cr. | 787 | 873/278 | 13.8 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 2,643 Cr. | 375 | 760/361 | 18.1 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,360 Cr. | 962 | 1,402/949 | 19.5 | 768 | 1.04 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,34,945 Cr. | 3,987 | 4,125/2,886 | 62.3 | 250 | 0.80 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 718 Cr. | 77.9 | 245/75.2 | | 41.3 | 0.64 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,221 Cr. | 13.0 | 23.5/11.5 | 19.4 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 14,182 Cr. | 371 | 1,328/356 | 41.3 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,199 Cr. | 138 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 3,90,588 Cr. | 1,628 | 1,851/1,547 | 32.2 | 324 | 0.98 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,262 Cr. | 517 | 734/441 | 353 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,951 Cr. | 315 | 360/175 | 36.4 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 5,622 Cr. | 287 | 502/260 | 36.3 | 125 | 0.17 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,293 Cr. | 4,035 | 6,718/3,976 | 25.2 | 340 | 2.90 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,273 Cr. | 1,979 | 2,725/1,772 | 31.2 | 335 | 1.01 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,662 Cr. | 5,218 | 6,739/4,904 | 28.2 | 373 | 2.40 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 141 Cr. | 39.9 | 76.2/37.1 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 20,820 Cr. | 4,551 | 5,993/3,701 | 29.5 | 841 | 0.77 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 111 Cr. | 89.9 | 203/81.0 | 11.4 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,250 Cr. | 367 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,420 Cr. | 674 | 1,512/604 | 65.4 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 16,829 Cr. | 13,117 | 19,748/10,060 | 86.0 | 1,263 | 0.09 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 269 Cr. | 13.9 | 38.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 14,757 Cr. | 824 | 1,341/660 | 9.59 | 483 | 0.73 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 1,964 Cr. | 35.8 | 70.5/33.5 | 26.0 | 21.8 | 0.56 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 7,459 Cr. | 165 | 276/156 | 21.2 | 59.3 | 0.49 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 57.1 Cr. | 36.1 | 116/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 253 Cr. | 70.8 | 157/67.8 | | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 97,150 Cr. | 2,129 | 2,228/1,774 | 22.5 | 430 | 0.56 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 931 Cr. | 465 | 809/440 | 11.6 | 357 | 0.39 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 51,742 Cr. | 954 | 1,141/512 | 64.6 | 91.1 | 0.13 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,092 Cr. | 1,052 | 1,235/596 | 22.2 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 123 Cr. | 56.6 | 114/53.0 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 595 Cr. | 123 | 215/120 | 35.9 | 104 | 2.43 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 565 Cr. | 327 | 500/265 | 20.5 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 15,296 Cr. | 958 | 1,250/802 | 30.8 | 414 | 0.52 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 30,119 Cr. | 1,865 | 1,939/1,303 | 40.0 | 243 | 0.83 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,123 Cr. | 169 | 302/155 | 26.4 | 37.9 | 1.48 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,452 Cr. | 1,440 | 1,595/1,168 | 36.8 | 293 | 0.28 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,113 Cr. | 72.1 | 127/57.5 | 18.2 | 59.7 | 1.11 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 19.9/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 898 Cr. | 109 | 124/67.2 | 19.0 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 1,952 Cr. | 212 | 350/190 | | 106 | 0.09 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,296 Cr. | 187 | 457/182 | 227 | 96.9 | 0.75 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,278 Cr. | 1,501 | 2,350/1,243 | 31.2 | 397 | 0.47 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 2,980 Cr. | 296 | 444/285 | 54.9 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,439 Cr. | 553 | 627/412 | 24.7 | 164 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 54,212 Cr. | 1,920 | 2,286/1,275 | 20.0 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 40,794 Cr. | 2,407 | 3,516/1,921 | 42.8 | 101 | 1.74 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 31,200 Cr. | 1,898 | 2,131/1,200 | 26.3 | 610 | 0.95 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,135 Cr. | 377 | 528/359 | 27.2 | 149 | 1.33 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 19,152 Cr. | 1,383 | 1,910/1,097 | 46.1 | 227 | 0.53 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 98,357 Cr. | 1,182 | 1,380/1,020 | 17.7 | 432 | 0.68 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,400 Cr. | 216 | 322/178 | 22.7 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,06,192 Cr. | 1,312 | 1,673/1,282 | 22.3 | 408 | 0.99 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 13,714 Cr. | 1,800 | 2,397/1,551 | 23.3 | 416 | 0.33 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 177 Cr. | 60.2 | 166/58.4 | 12.6 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,813 Cr. | 173 | 196/105 | 16.5 | 107 | 0.29 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 69.5 Cr. | 42.1 | 58.0/28.5 | 24.4 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 59,941 Cr. | 370 | 425/291 | 126 | 200 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,434 Cr. | 1,421 | 2,000/1,385 | 31.7 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 106 Cr. | 66.9 | 129/64.0 | 15.5 | 49.2 | 1.79 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 281 Cr. | 120 | 205/67.8 | 26.5 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 21,552 Cr. | 8,630 | 10,691/6,502 | 93.2 | 320 | 0.37 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,644 Cr. | 575 | 791/544 | 29.0 | 118 | 0.80 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 141 Cr. | 67.1 | 125/61.0 | 7.51 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 66,083 Cr. | 5,522 | 5,934/4,492 | 28.1 | 1,116 | 0.81 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 15,385 Cr. | 782 | 1,108/725 | 24.2 | 271 | 1.41 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 394 Cr. | 684 | 1,219/663 | | 690 | 0.73 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 34,810 Cr. | 2,786 | 3,080/2,022 | 34.3 | 345 | 1.01 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 2,969 Cr. | 266 | 367/258 | 20.6 | 133 | 1.96 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,490 Cr. | 384 | 575/312 | 18.3 | 147 | 0.26 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,464.08 Cr | 1,084.45 | | 46.05 | 202.32 | 0.38% | 16.29% | 15.20% | 6.10 |